The stringent regulations on safety monitoring increased the safety in data collection, analysis and regulatory surveillance. Adding to this the rising demand for drugs, the amplified need for novel therapeutics development via extensive clinical trials and the world population growth made drug manufacturers start paying more attention to Pharmacovigilance.

Artificial Intelligence promises vast opportunities for economic and societal benefits in the pharmaceutical industry, lifesciences and healthcare including care delivery with digital health. As data applications supported by AI become more advanced, the whole healthcare value chain has been affected. New forms of drug discoveries are going to evolve.

Smithers’ 9th annual Extractables and Leachables USA conference is returning to Bethesda, MD,  October 26-28, 2020. This is a unique event in the extractables and leachables industry, bringing together top companies from the entire supply chain; making it easy to network with peers, and leading to new, beneficial connections.